Research Horizons


Most-Shared Research from November 2020

The largest compilation to date of how the COVID-19 pandemic has affected children also was the most-shared research publication  authored or co-authored by an investigator at Cincinnati Children’s.

The report, published in JAMA Pediatrics, compiled data on more than 135,000 children tested or treated at seven leading pediatric medical centers.  The Cincinnati Children’s co-author on the study was Nathan Pajor, MD, who was interviewed Nov. 23, 2020, on WVXU.

The paper was specifically cited in more than 65 articles posted by news organizations. Meanwhile, more than 900 tweets delivered the findings to more than 3.5 million followers, combined.

Find out more about this and other highly-shared studies by clicking on any of the badges below.


Assessment of 135 794 Pediatric Patients Tested for Severe Acute Respiratory Syndrome Coronavirus 2 Across the United States

JAMA Pediatrics
Cincinnati Children’s co-author: Nathan Pajor, MD

Use of Intravenous Gadolinium-based Contrast Media in Patients with Kidney Disease: Consensus Statements from the American College of Radiology and the National Kidney Foundation

Cincinnati Children’s co-author: Jonathan Dillman, MD, MSc

Imaging of Neurologic Disease in Hospitalized Patients with COVID-19: An Italian Multicenter Retrospective Observational Study

Cincinnati Children’s co-author: Bin Zhang, PhD

Transferring allergies in the womb

Cincinnati Children’s co-author: Marc Rothenberg, MD, PhD

Altered intestinal ACE2 levels are associated with inflammation, severe disease and response to anti-cytokine therapy in IBD

Cincinnati Children’s co-author: Lee Denson, MD

Prepronociceptin-Expressing Neurons in the Extended Amygdala Encode and Promote Rapid Arousal Responses to Motivationally Salient Stimuli

Cell Reports
Cincinnati Children’s co-author: J. Elliott Robinson, MD, PhD

The R2 non-neuroinvasive HSV-1 vaccine affords protection from genital HSV-2 infections in a guinea pig model

npj Vaccines
Cincinnati Children’s lead author: David I. Bernstein, MD, MA

Efficacy and safety of mepolizumab in hypereosinophilic syndrome: A phase III, randomized, placebo-controlled trial

The Journal of Allergy and Clinical Immunology
Cincinnati Children’s co-author: Marc Rothenberg, MD, PhD